These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 29681623)

  • 21. Proton pump inhibitor-refractory gastroesophageal reflux disease: current diagnosis and management.
    Frazzoni L; Fuccio L; Frazzoni M
    Minerva Gastroenterol Dietol; 2017 Sep; 63(3):249-256. PubMed ID: 28251845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of baseline impedance in patients with proton pump inhibitor-refractory nonerosive reflux disease.
    Kohata Y; Fujiwara Y; Yamagami H; Tanigawa T; Shiba M; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():36-40. PubMed ID: 25827802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Applying Lyon Consensus criteria in the work-up of patients with proton pump inhibitory-refractory heartburn.
    Frazzoni M; Frazzoni L; Ribolsi M; Bortoli N; Tolone S; Russo S; Conigliaro R; Penagini R; Fuccio L; Zagari RM; Savarino E
    Aliment Pharmacol Ther; 2022 Jun; 55(11):1423-1430. PubMed ID: 35229321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reflux parameters as modified by laparoscopic fundoplication in 40 patients with heartburn/regurgitation persisting despite PPI therapy: a study using impedance-pH monitoring.
    Frazzoni M; Conigliaro R; Melotti G
    Dig Dis Sci; 2011 Apr; 56(4):1099-106. PubMed ID: 20737211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response of eosinophilic oesophagitis to proton pump inhibitors is associated with impedance-pH parameters implying anti-reflux mechanism of action.
    Frazzoni M; Frazzoni L; De Bortoli N; Russo S; Tolone S; Arsiè E; Conigliaro R; Penagini R; Savarino E
    Aliment Pharmacol Ther; 2021 Jun; 53(11):1183-1189. PubMed ID: 33857331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease.
    Ribolsi M; Cicala M; Zentilin P; Neri M; Mauro A; Efthymakis K; Petitti T; Savarino V; Penagini R
    Aliment Pharmacol Ther; 2018 Nov; 48(10):1074-1081. PubMed ID: 30294924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective validation of reflux monitoring by impedance-pH in predicting PPI response in typical GERD.
    Ribolsi M; Savarino E; Frazzoni M; Cicala M
    Dig Liver Dis; 2023 Jun; 55(6):721-726. PubMed ID: 36572569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Refractory gastroesophageal reflux disease as diagnosed by impedance-pH monitoring can be cured by laparoscopic fundoplication.
    Frazzoni M; Piccoli M; Conigliaro R; Manta R; Frazzoni L; Melotti G
    Surg Endosc; 2013 Aug; 27(8):2940-6. PubMed ID: 23436097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Esophageal Nocturnal Baseline Impedance and Post-reflux Swallow-induced Peristaltic Wave Index in Identifying Proton Pump Inhibitor-refractory Non-erosive Reflux Disease.
    Wang Y; Ye B; Wang M; Lin L; Jiang L
    J Neurogastroenterol Motil; 2021 Oct; 27(4):525-532. PubMed ID: 34642272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of Lyon Consensus criteria for GORD diagnosis: evaluation of conventional and new impedance-pH parameters.
    Frazzoni L; Frazzoni M; De Bortoli N; Ribolsi M; Tolone S; Russo S; Conigliaro RL; Penagini R; Fuccio L; Zagari RM; Savarino E
    Gut; 2022 Jun; 71(6):1062-1067. PubMed ID: 34376517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of the pH Value of Refluxate and Proximal Extent on Heartburn Perception in Patients with Proton Pump Inhibitor-Refractory Non-Erosive Reflux Disease.
    Abe Y; Koike T; Saito M; Okata T; Norita K; Kikuchi H; Nakagawa K; Hatta W; Asanuma K; Uno K; Asano N; Imatani A; Shimosegawa T; Masamune A
    Digestion; 2020; 101(4):375-381. PubMed ID: 31357199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Manually calculated oesophageal bolus clearance time increases in parallel with reflux severity at impedance-pH monitoring.
    de Bortoli N; Martinucci I; Savarino EV; Frazzoni M; Tutuian R; Tolone S; Piaggi P; Furnari M; Russo S; Bertani L; Macchia L; Savarino V; Marchi S
    Dig Liver Dis; 2015 Dec; 47(12):1027-32. PubMed ID: 26362613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Results From Up-Front Esophageal Testing Predict Proton Pump Inhibitor Response in Patients With Chronic Cough.
    Ribolsi M; Luca Guarino MP; Balestrieri P; Altomare A; Tullio A; Petitti T; Cicala M
    Am J Gastroenterol; 2021 Nov; 116(11):2199-2206. PubMed ID: 34287222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn.
    Frazzoni M; Conigliaro R; Mirante VG; Melotti G
    Neurogastroenterol Motil; 2012 Feb; 24(2):141-6, e87. PubMed ID: 21988704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy.
    Frazzoni M; Savarino E; Manno M; Melotti G; Mirante VG; Mussetto A; Bertani H; Manta R; Conigliaro R
    Aliment Pharmacol Ther; 2009 Sep; 30(5):508-15. PubMed ID: 19519732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proximal esophageal impedance baseline increases the yield of impedance-pH monitoring for GERD diagnosis and is associated with heartburn response to PPI.
    Ribolsi M; Frazzoni M; Marchetti L; Brigida M; Cicala M; Savarino E
    Neurogastroenterol Motil; 2023 Aug; 35(8):e14612. PubMed ID: 37203462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients.
    Rinsma NF; Farré R; Bouvy ND; Masclee AA; Conchillo JM
    Neurogastroenterol Motil; 2015 Feb; 27(2):220-8. PubMed ID: 25348594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences Between Patients with Heartburn Refractory to Vonoprazan and Those Refractory to Proton Pump Inhibitors.
    Matsumura T; Sonoda M; Okimoto K; Dao HV; Takahashi S; Akizue N; Horio R; Goto C; Kurosugi A; Kaneko T; Ohta Y; Taida T; Kikuchi A; Fujie M; Kato J; Kato N
    Dig Dis Sci; 2024 Jun; 69(6):2132-2139. PubMed ID: 38622462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.